Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone
Authors:
- Y. IlanYIY. Ilan
- 1 June 2004
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 40 (9) , 1397-1403
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Growth inhibition of prostate cancer xenografts by halofuginone*†The Prostate, 2002
- Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal developmentSeminars in Cancer Biology, 2002
- Chronic liver injury, TGF-β, and cancerExperimental & Molecular Medicine, 2001
- Interactions between Hepatic Stellate Cells and the Immune SystemSeminars in Liver Disease, 2001
- Hepatic Stellate Cells as a Target for the Treatment of Liver FibrosisSeminars in Liver Disease, 2001
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachJournal of Hepatology, 2001
- Cell-specific regulation of 1(III) and 2(V) collagen by TGF- 1 in tubulointerstitial cell modelsNephrology Dialysis Transplantation, 1998
- Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigenJournal of Hepatology, 1997
- Inhibition of Collagen Synthesis, Smooth Muscle Cell Proliferation, and Injury-Induced Intimal Hyperplasia by HalofuginoneArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993